GSK4028
Modify Date: 2024-01-10 22:15:42
GSK4028 structure
|
Common Name | GSK4028 | ||
|---|---|---|---|---|
| CAS Number | 2079886-19-2 | Molecular Weight | 377.28 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H21BrN4O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK4028GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9 in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. |
| Name | GSK4028 |
|---|
| Description | GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9 in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. |
|---|---|
| Related Catalog | |
| Target |
pIC50: 4.9 (PCAF/GCN5)[1]. |
| In Vitro | GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9. GSK4028 also demonstrates potency toward BRD4 BD1 and BRD9 inTR-FRET assay with pIC50s of <4.3 and 4.5±0.13, respectively[1]. |
| References |
| Molecular Formula | C17H21BrN4O |
|---|---|
| Molecular Weight | 377.28 |
| Storage condition | 2-8℃ |